A previous study has indicated that insulin resistance is usually presented in individuals with NAFLD, in which insulin cannot inhibit the lipolysis rate of white adipose tissue, allowing large amounts of free fatty acids entry into the liver [37]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.